Intracellular drug concentrations

Clinical Pharmacology and Therapeutics

Volumn 93, Issue 3, 2013, Pages 263-266

  Dollery, C T ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CHLOROQUINE; MULTIDRUG RESISTANCE PROTEIN 1; PHOSPHOLIPASE; PHOSPHOLIPID;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; AUTOPHAGOSOME; BLOOD BRAIN BARRIER; CELL LEVEL; CELL MEMBRANE PERMEABILITY; CELL PH; CELLULAR DISTRIBUTION; CYTOPLASM; DRUG BLOOD LEVEL; DRUG CONCENTRATION; DRUG CYTOPLASM LEVEL; DRUG SAFETY; DRUG TRANSPORT; ENDOPLASMIC RETICULUM; HUMAN; INTRACELLULAR MEMBRANE; LASER CAPTURE MICRODISSECTION; LIPIDOSIS; LIVER TOXICITY; MASS SPECTROMETRY; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; PROTON TRANSPORT; RESPIRATORY CHAIN; REVIEW; WHOLE BODY AUTORADIOGRAPHY;

ANIMALS; BIOLOGICAL TRANSPORT; HUMANS; LYSOSOMES; MASS SPECTROMETRY; PERMEABILITY; PHARMACEUTICAL PREPARATIONS;

EID: 84874190353     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2012.240     Document Type: Review

References (17)

1. Monro, A.M. Interspecies comparisons in toxicology: The utility and futility of plasma concentrations of the test substance. Regul. Toxicol. Pharmacol. 12, 137-160 (1990
2. Lipinski, C.A. Drug-like properties and the cause of poor solubility and permeability. J. Pharmacol. Toxicol. Methods 44, 235-249 (2000
3. Solon, E.G. Use of radioactive compounds and autoradiography to determine drug tissue distribution. Chem. Res. Toxicol. 25, 543-555 (2012
4. Roth, M., Obaidat, A. & Hagenbuch, B. OATPs, OATs and OCTs: The organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Br. J. Pharmacol. 165, 1260-1287 (2012
5. The SEARCH Collaborative Group. SLCO1B1 variants and statin-induced myopathy - a genomewide study. N. Engl. J. Med. 359:789-799 (2008
6. Shu, Y. et al. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J. Clin. Invest. 117, 1422-1431 (2007
7. Schinkel, A.H. P-Glycoprotein, a gatekeeper in the blood-brain barrier. Adv. Drug Deliv. Rev. 36, 179-194, (1999
8. Ball, K.K., Bouzom, F., Scherrmann, J.M., Walther, B. & Declèves, X. Development of a physiologically based pharmacokinetic model for the rat central nervous system and determination of an in vitro-in vivo scaling methodology for the blood-brain barrier permeability of two transporter substrates, morphine and oxycodone. J. Pharm. Sci. 101, 4277-4292 (2012
9. Shitara, Y., Horie, T. & Sugiyama, Y. Transporters as a determinant of drug clearance and tissue distribution. Eur. J. Pharm. Sci. 27, 425-446 (2006
10. A ndreev, E., Koopman, M. & Arisz, L. A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible? J. Intern. Med. 246, 247-252 (1999
11. H ostetler, K.Y., Reasor, M. & Yazaki, P.J. Chloroquine-induced phospholipid fatty liver. Measurement of drug and lipid concentrations in rat liver lysosomes. J. Biol. Chem. 260, 215-219 (1985
12. Bazzoli, C., Jullien, V., Le Tiec, C., Rey, E., Mentré, F. & Taburet, A.M. Intracellular pharmacokinetics of antiretroviral drugs in HIV-infected patients, and their correlation with drug action. Clin. Pharmacokinet. 49, 17-45 (2010
13. Cutler, M.J. & Choo, E.F. Overview of SLC22A and SLCO families of drug uptake transporters in the context of cancer treatments. Curr. Drug Metab. 793-807 (2011
14. Brinkman, K., Smeitink, J.A., Romijn, J.A. & Reiss, P. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet 354, 1112-1115 (1999
15. Trim, P.J., Francese, S. & Clench, M.R. Imaging mass spectrometry for the assessment of drugs and metabolites in tissue. Bioanalysis 1, 309-319 (2009
16. Boxer, S.G., Kraft, M.L. & Weber, P.K. Advances in imaging secondary ion mass spectrometry for biological samples. Annu. Rev. Biophys. 38, 53-74 (2009
17. Nies, A.T., Koepsell, H., Damme, K. & Schwab, M. Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy. Handb. Exp. Pharmacol. 201, 105-167 (2011